Literature DB >> 31987943

Decoding allosteric communication pathways in protein lysine acetyltransferase.

Ashfaq Ur Rehman1, Mueed Ur Rahman1, Shaoyong Lu2, Hao Liu1, Jia-Yi Li1, Taaha Arshad1, Abdul Wadood3, Ho Leung Ng4, Hai-Feng Chen5.   

Abstract

In bacteria, protein lysine acetylation circuits can control core processes such as carbon metabolism. In E. coli, cyclic adenosine monophosphate (cAMP) controls the transcription level and activity of protein lysine acetyltransferase (PAT). The M. tuberculosis PatA (Mt-PatA) resides in two different conformations; the activated state and autoinhibited state. However, the mechanism of cAMP allosteric regulation of Mt-PatA remains mysterious. Here, we performed extensive all-atom molecular dynamics (MD) simulations (three independent run for each system) and built a residue-residue dynamic correlation network to show how cAMP mediates allosteric activation. cAMP binds at the regulatory site in the regulatory domain, which is 32 Å away from the catalytic site. An extensive conformational restructuring relieves autoinhibition caused by a molecular Lid (residues 161-203) that shelters the substrate-binding surface. In the activated state, the regulatory domain rotates (~40°) around Ser144, which links both domains. Rotation removes the C-terminus from the cAMP site and relieves the autoinhibited state. Also, the molecular Lid refolds and creates an activator binding site. A conserved residue, His173, was mutated into Lys in the Lid, and during an MD trajectory of the activated state, positioned itself near an acetyl donor molecule in the catalytic domain, suggesting a direct mechanism for acetylation. This study describes the allosteric framework for Mt-PatA and prerequisite intermediate states that permit long-distance signal transmission.
Copyright © 2020. Published by Elsevier B.V.

Entities:  

Keywords:  Allosteric auto-inhibition; Autoacetylation; Latching mechanism; Protein lysine acetyltransferase; Regulatory element (C-terminus & lid)

Mesh:

Substances:

Year:  2020        PMID: 31987943     DOI: 10.1016/j.ijbiomac.2020.01.213

Source DB:  PubMed          Journal:  Int J Biol Macromol        ISSN: 0141-8130            Impact factor:   6.953


  5 in total

1.  Quinoline-Pyrazole Scaffold as a Novel Ligand of Galectin-3 and Suppressor of TREM2 Signaling.

Authors:  Moustafa Gabr; Ashfaq Ur Rehman; Hai-Feng Chen
Journal:  ACS Med Chem Lett       Date:  2020-08-11       Impact factor: 4.345

2.  Anti-inflammatory and In Silico Docking Studies of Heterophragma adenophyllum Seem Stem Constituents.

Authors:  Tareq Abu-Izneid; Zafar Ali Shah; Abdur Rauf; Abdul Wadood; Saud Bawazeer; Naveed Muhammad; Mohamed A El-Esawi; Fahad A Alhumaydhi; Abdullah S M Aljohani; Eman El-Sharkawy; Mohammad S Mubarak; Kuralay Isayeva; Mohammad Ali Shariati
Journal:  Inflammation       Date:  2020-09-08       Impact factor: 4.092

3.  Dihydroquinazolin-4(1H)-one derivatives as novel and potential leads for diabetic management.

Authors:  Oluwatoyin Babatunde; Shehryar Hameed; Uzma Salar; Sridevi Chigurupati; Abdul Wadood; Ashfaq Ur Rehman; Vijayan Venugopal; Khalid Mohammed Khan; Muhammad Taha; Shahnaz Perveen
Journal:  Mol Divers       Date:  2021-03-01       Impact factor: 2.943

4.  In vivo analgesic, anti-inflammatory, and sedative activity and a molecular docking study of dinaphthodiospyrol G isolated from Diospyros lotus.

Authors:  Abdur Rauf; Tareq Abu-Izneid; Fahad A Alhumaydhi; Naveed Muhammad; Abdullah S M Aljohani; Saima Naz; Saud Bawazeer; Abdul Wadood; Mohammad S Mubarak
Journal:  BMC Complement Med Ther       Date:  2020-07-25

5.  Deciphering the Mechanism of Gilteritinib Overcoming Lorlatinib Resistance to the Double Mutant I1171N/F1174I in Anaplastic Lymphoma Kinase.

Authors:  Shuai Liang; Qing Wang; Xuesen Qi; Yudi Liu; Guozhen Li; Shaoyong Lu; Linkai Mou; Xiangyu Chen
Journal:  Front Cell Dev Biol       Date:  2021-12-23
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.